The following was from a 7000 patient study publis
Post# of 72440
(Total Views: 711)
Posted On: 09/17/2022 9:37:59 AM
The following was from a 7000 patient study published by the British Medical Journal (BMJ).that found that death rates actually increased 3.4% using remdesivir with Critical Covid and only slightly decreased 1.3% using remdesivir with Severe Covid.
=====================
The recommendation against the use of remdesivir in critical COVID-19 infections was based on a randomised trial involving over 7,000 patients. The study found 34 more deaths per 1,000 patients in cases of critical COVID-19 when remdesivir was administered. By contrast, the trial showed 13 fewer deaths per 1,000 patients when the drug was given to patients with only a severe infection.
=====================
The recommendation against the use of remdesivir in critical COVID-19 infections was based on a randomised trial involving over 7,000 patients. The study found 34 more deaths per 1,000 patients in cases of critical COVID-19 when remdesivir was administered. By contrast, the trial showed 13 fewer deaths per 1,000 patients when the drug was given to patients with only a severe infection.
(2)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼